Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 371

1.

Treatment options and recommendations to reduce preterm births in women with short cervix.

Slager J, Lynne S.

J Midwifery Womens Health. 2012 Jul;57 Suppl 1:S12-8. doi: 10.1111/j.1542-2011.2012.00210.x.

PMID:
22776244
2.

Vaginal progesterone to prevent preterm birth in pregnant women with a sonographic short cervix: clinical and public health implications.

Conde-Agudelo A, Romero R.

Am J Obstet Gynecol. 2016 Feb;214(2):235-42. doi: 10.1016/j.ajog.2015.09.102. Epub 2015 Oct 9.

PMID:
26450404
3.

Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial.

Hassan SS, Romero R, Vidyadhari D, Fusey S, Baxter JK, Khandelwal M, Vijayaraghavan J, Trivedi Y, Soma-Pillay P, Sambarey P, Dayal A, Potapov V, O'Brien J, Astakhov V, Yuzko O, Kinzler W, Dattel B, Sehdev H, Mazheika L, Manchulenko D, Gervasi MT, Sullivan L, Conde-Agudelo A, Phillips JA, Creasy GW; PREGNANT Trial.

Ultrasound Obstet Gynecol. 2011 Jul;38(1):18-31. doi: 10.1002/uog.9017. Epub 2011 Jun 15.

4.

Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis.

Conde-Agudelo A, Romero R, Nicolaides K, Chaiworapongsa T, O'Brien JM, Cetingoz E, da Fonseca E, Creasy G, Soma-Pillay P, Fusey S, Cam C, Alfirevic Z, Hassan SS.

Am J Obstet Gynecol. 2013 Jan;208(1):42.e1-42.e18. doi: 10.1016/j.ajog.2012.10.877. Epub 2012 Nov 15. Review.

5.

[Prevention of spontaneous preterm birth (excluding preterm premature rupture of membranes): Guidelines for clinical practice - Text of the Guidelines (short text)].

Sentilhes L, Sénat MV, Ancel PY, Azria E, Benoist G, Blanc J, Brabant G, Bretelle F, Brun S, Doret M, Ducroux-Schouwey C, Evrard A, Kayem G, Maisonneuve E, Marcellin L, Marret S, Mottet N, Paysant S, Riethmuller D, Rozenberg P, Schmitz T, Torchin H, Langer B.

J Gynecol Obstet Biol Reprod (Paris). 2016 Dec;45(10):1446-1456. doi: 10.1016/j.jgyn.2016.09.011. Epub 2016 Nov 9. Review. French.

PMID:
27836377
6.

Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial.

DeFranco EA, O'Brien JM, Adair CD, Lewis DF, Hall DR, Fusey S, Soma-Pillay P, Porter K, How H, Schakis R, Eller D, Trivedi Y, Vanburen G, Khandelwal M, Trofatter K, Vidyadhari D, Vijayaraghavan J, Weeks J, Dattel B, Newton E, Chazotte C, Valenzuela G, Calda P, Bsharat M, Creasy GW.

Ultrasound Obstet Gynecol. 2007 Oct;30(5):697-705.

7.

Cost-effectiveness of transvaginal ultrasound cervical length screening in singletons without a prior preterm birth: an update.

Werner EF, Hamel MS, Orzechowski K, Berghella V, Thung SF.

Am J Obstet Gynecol. 2015 Oct;213(4):554.e1-6. doi: 10.1016/j.ajog.2015.06.020. Epub 2015 Jun 10.

PMID:
26071914
8.

Progesterone to prevent spontaneous preterm birth.

Romero R, Yeo L, Chaemsaithong P, Chaiworapongsa T, Hassan SS.

Semin Fetal Neonatal Med. 2014 Feb;19(1):15-26. doi: 10.1016/j.siny.2013.10.004. Epub 2013 Dec 5. Review.

9.

Vaginal progesterone for prevention of preterm labor in asymptomatic twin pregnancies with sonographic short cervix: a randomized clinical trial of efficacy and safety.

El-refaie W, Abdelhafez MS, Badawy A.

Arch Gynecol Obstet. 2016 Jan;293(1):61-7. doi: 10.1007/s00404-015-3767-1. Epub 2015 Jun 5.

PMID:
26044148
10.

Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial.

Norman JE, Marlow N, Messow CM, Shennan A, Bennett PR, Thornton S, Robson SC, McConnachie A, Petrou S, Sebire NJ, Lavender T, Whyte S, Norrie J; OPPTIMUM study group.

Lancet. 2016 May 21;387(10033):2106-16. doi: 10.1016/S0140-6736(16)00350-0. Epub 2016 Feb 24.

11.

Vaginal progesterone, cerclage or cervical pessary for preventing preterm birth in asymptomatic singleton pregnant women with a history of preterm birth and a sonographic short cervix.

Alfirevic Z, Owen J, Carreras Moratonas E, Sharp AN, Szychowski JM, Goya M.

Ultrasound Obstet Gynecol. 2013 Feb;41(2):146-51. doi: 10.1002/uog.12300. Epub 2013 Jan 17.

12.

Evaluation of two treatment strategies for the prevention of preterm birth in women identified as at risk by ultrasound (PESAPRO Trial): study protocol for a randomized controlled trial.

Cabrera-García L, Cruz-Melguizo S, Ruiz-Antorán B, Torres F, Velasco A, Martínez-Payo C, Avendaño-Solá C; PESAPRO trial Group.

Trials. 2015 Sep 25;16:427. doi: 10.1186/s13063-015-0964-y.

13.

A blueprint for the prevention of preterm birth: vaginal progesterone in women with a short cervix.

Romero R, Yeo L, Miranda J, Hassan SS, Conde-Agudelo A, Chaiworapongsa T.

J Perinat Med. 2013 Jan;41(1):27-44. doi: 10.1515/jpm-2012-0272. Review.

14.

Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety.

O'Brien JM, Lewis DF.

Am J Obstet Gynecol. 2016 Jan;214(1):45-56. doi: 10.1016/j.ajog.2015.10.934. Epub 2015 Nov 10. Review.

PMID:
26558340
15.

Preventing Preterm Birth with Progesterone in Women with a Short Cervical Length from a Low-Risk Population: A Multicenter Double-Blind Placebo-Controlled Randomized Trial.

van Os MA, van der Ven AJ, Kleinrouweler CE, Schuit E, Kazemier BM, Verhoeven CJ, de Miranda E, van Wassenaer-Leemhuis AG, Sikkema JM, Woiski MD, Bossuyt PM, Pajkrt E, de Groot CJ, Mol BW, Haak MC.

Am J Perinatol. 2015 Aug;32(10):993-1000. doi: 10.1055/s-0035-1547327. Epub 2015 Mar 4.

PMID:
25738790
16.

Vaginal progesterone to reduce the rate of preterm birth and neonatal morbidity: a solution at last.

Romero R.

Womens Health (Lond). 2011 Sep;7(5):501-4. doi: 10.2217/whe.11.60. No abstract available.

17.

[Prevention of preterm birth with vaginal progesterone in women with preterm labor: which are the evidences?].

Martinez de Tejada B, Othenin-Girard V, Irion O.

Rev Med Suisse. 2015 Oct 28;11(492):2004, 2006-8, 2010. French.

PMID:
26672179
18.

Effectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta-analysis.

Schuit E, Stock S, Rode L, Rouse DJ, Lim AC, Norman JE, Nassar AH, Serra V, Combs CA, Vayssiere C, Aboulghar MM, Wood S, Çetingöz E, Briery CM, Fonseca EB, Worda K, Tabor A, Thom EA, Caritis SN, Awwad J, Usta IM, Perales A, Meseguer J, Maurel K, Garite T, Aboulghar MA, Amin YM, Ross S, Cam C, Karateke A, Morrison JC, Magann EF, Nicolaides KH, Zuithoff NP, Groenwold RH, Moons KG, Kwee A, Mol BW; Global Obstetrics Network (GONet) collaboration.

BJOG. 2015 Jan;122(1):27-37. doi: 10.1111/1471-0528.13032. Epub 2014 Aug 22. Review.

19.

Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis.

Norman JE, Mackenzie F, Owen P, Mactier H, Hanretty K, Cooper S, Calder A, Mires G, Danielian P, Sturgiss S, MacLennan G, Tydeman G, Thornton S, Martin B, Thornton JG, Neilson JP, Norrie J.

Lancet. 2009 Jun 13;373(9680):2034-40. doi: 10.1016/S0140-6736(09)60947-8.

20.

The Preterm Prediction Study: sequential cervical length and fetal fibronectin testing for the prediction of spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.

Goldenberg RL, Iams JD, Das A, Mercer BM, Meis PJ, Moawad AH, Miodovnik M, VanDorsten JP, Caritis SN, Thurnau GR, Dombrowski MP, Roberts JM, McNellis D.

Am J Obstet Gynecol. 2000 Mar;182(3):636-43.

PMID:
10739521

Supplemental Content

Support Center